image
Chimerix, Inc. CMRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.8599
-4.32 %
$ 77.3 M
Market Cap
-0.91
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -99.04% -47.68% -54.12%
Annual Report FY 10-K 2022-12-31 1609.15% 167.31% 65.18%
Annual Report FY 10-K 2021-12-31 -63.16% -507.21% -289.52%
Annual Report FY 10-K 2020-12-31 -57.09% 75.74% -328.70%
Annual Report FY 10-K 2019-12-31 73.49% -149.95% 118.91%
Annual Report FY 10-K 2018-12-31 60.57% 2.13% 0.69%
Annual Report FY 10-K 2017-12-31 -21.19% 7.08% 7.50%
Annual Report FY 10-K 2016-12-31 -47.02% 34.92% 34.08%
Annual Report FY 10-K 2015-12-31 166.39% -97.89% -100.88%
Annual Report FY 10-K 2014-12-31 -7.55% -62.74% -105.69%
Annual Report FY 10-K 2013-12-31 -87.04% -727.17% -928.35%
Annual Report FY 10-K 2012-12-31 178.65% 82.78% 88.86%
Annual Report FY 10-K 2011-12-31 605.60% -0.52% 1.23%
Annual Report FY 10-K 2010-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 136.36% 4.62% 7.10%
Quarterly Report Q2 8-K 2024-06-30 396.15% -11.35% -6.95%
Quarterly Report Q1 8-K 2024-03-31 0.00% -18.04% -0.71%
Quarterly Report Q4 8-K 2023-12-31 -99.51% 13.35% 12.61%
Quarterly Report Q3 8-K 2023-09-30 -99.97% -9.94% -229.17%
Quarterly Report Q2 8-K 2023-06-30 -94.09% 20.92% 8.95%
Quarterly Report Q1 8-K 2023-03-31 1786.67% 25.19% 2.23%
Quarterly Report Q4 8-K 2022-12-31 1669.57% 46.93% 39.76%
Quarterly Report Q3 8-K 2022-09-30 30325.23% 1400.44% 162.61%
Quarterly Report Q2 8-K 2022-06-30 12.53% -32.24% -31.61%
Quarterly Report Q1 8-K 2022-03-31 -98.95% 74.58% 74.58%
Quarterly Report Q4 8-K 2021-12-31 -95.89% -238.31% -236.24%
Quarterly Report Q3 8-K 2021-09-30 -93.35% -62.65% -60.90%
Quarterly Report Q2 8-K 2021-06-30 -72.11% -77.35% -73.20%
Quarterly Report Q1 8-K 2021-03-31 15.63% -834.88% -793.00%
Quarterly Report Q4 8-K 2020-12-31 -83.45% -233.29% -203.56%
Quarterly Report Q3 8-K 2020-09-30 -17.82% 84.52% 84.50%
Quarterly Report Q2 8-K 2020-06-30 -2.50% 43.25% 45.00%
Quarterly Report Q1 8-K 2020-03-31 -47.33% 41.11% 42.09%
Quarterly Report Q4 8-K 2019-12-31 39.12% 76.58% 74.88%
Quarterly Report Q3 8-K 2019-09-30 430.62% -358.55% -346.22%
Quarterly Report Q2 8-K 2019-06-30 20.54% 5.17% 2.44%
Quarterly Report Q1 8-K 2019-03-31 198.23% 10.76% 7.20%
Quarterly Report Q4 8-K 2018-12-31 163.77% 22.26% 17.49%
Quarterly Report Q3 8-K 2018-09-30 -58.86% 7.12% 6.70%
Quarterly Report Q2 8-K 2018-06-30 76.74% -11.59% -11.16%
Quarterly Report Q1 8-K 2018-03-31 -26.72% -11.67% -11.21%
Quarterly Report Q4 8-K 2017-12-31 -6.87% -28.62% -21.56%
Quarterly Report Q3 8-K 2017-09-30 37.37% -1.69% -2.81%
Quarterly Report Q2 8-K 2017-06-30 -63.34% 8.09% 6.91%
Quarterly Report Q1 8-K 2017-03-31 -12.21% 32.39% 31.44%
Quarterly Report Q4 8-K 2016-12-31 -36.33% 60.48% 59.78%
Quarterly Report Q3 8-K 2016-09-30 -71.25% 47.53% 46.80%
Quarterly Report Q2 8-K 2016-06-30 -55.56% 26.87% 25.75%
Quarterly Report Q1 8-K 2016-03-31 -0.81% -17.94% -19.27%
Quarterly Report Q4 8-K 2015-12-31 169.03% -86.90% -88.98%
Quarterly Report Q3 8-K 2015-09-30 91.65% -91.43% -94.23%
Quarterly Report Q2 8-K 2015-06-30 350.82% -111.48% -115.17%
Quarterly Report Q1 8-K 2015-03-31 58.72% -114.51% -119.26%
Quarterly Report Q4 8-K 2014-12-31 31.51% -147.73% -153.52%
Quarterly Report Q3 8-K 2014-09-30 29.93% -152.77% -161.96%
Quarterly Report Q2 8-K 2014-06-30 13.74% 5.82% -51.46%
Quarterly Report Q1 8-K 2014-03-31 -55.96% -13.98% -55.53%
Quarterly Report Q4 8-K 2013-12-31 -75.45% -88.93% -92.57%
Quarterly Report Q3 8-K 2013-09-30 -95.63% -60.19% -57.10%
Quarterly Report Q2 8-K 2013-06-30 -86.98% -188.14% -73.13%
Quarterly Report Q1 8-K 2013-03-31 -42.46% -32.02% -19.27%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2012-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2012-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2012-03-31 0.00% 0.00% 0.00%